These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 26426483

  • 1. Gold-installed biostable nanocomplexes for tumor-targeted siRNA delivery in vivo.
    Heo R, Yoon HY, Ko H, Shin JM, Jeon J, Chae YS, Kang YM, Kim D, Lee DS, Park JH.
    Chem Commun (Camb); 2015 Dec 04; 51(93):16656-9. PubMed ID: 26426483
    [Abstract] [Full Text] [Related]

  • 2. Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting.
    Yoon HY, Kim HR, Saravanakumar G, Heo R, Chae SY, Um W, Kim K, Kwon IC, Lee JY, Lee DS, Park JC, Park JH.
    J Control Release; 2013 Dec 28; 172(3):653-61. PubMed ID: 24055507
    [Abstract] [Full Text] [Related]

  • 3. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y, Kim HJ, Mi P, Zheng M, Takemoto H, Toh K, Kim BS, Hayashi K, Naito M, Matsumoto Y, Miyata K, Kataoka K.
    J Control Release; 2016 Dec 28; 244(Pt B):247-256. PubMed ID: 27590214
    [Abstract] [Full Text] [Related]

  • 4. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
    Sardo C, Bassi B, Craparo EF, Scialabba C, Cabrini E, Dacarro G, D'Agostino A, Taglietti A, Giammona G, Pallavicini P, Cavallaro G.
    Int J Pharm; 2017 Mar 15; 519(1-2):113-124. PubMed ID: 28093325
    [Abstract] [Full Text] [Related]

  • 5. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A.
    Toxicol Appl Pharmacol; 2009 Apr 01; 236(1):97-108. PubMed ID: 19371615
    [Abstract] [Full Text] [Related]

  • 6. Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity.
    Perche F, Yi Y, Hespel L, Mi P, Dirisala A, Cabral H, Miyata K, Kataoka K.
    Biomaterials; 2016 Jun 01; 90():62-71. PubMed ID: 26986857
    [Abstract] [Full Text] [Related]

  • 7. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ, Takemoto H, Yi Y, Zheng M, Maeda Y, Chaya H, Hayashi K, Mi P, Pittella F, Christie RJ, Toh K, Matsumoto Y, Nishiyama N, Miyata K, Kataoka K.
    ACS Nano; 2014 Sep 23; 8(9):8979-91. PubMed ID: 25133608
    [Abstract] [Full Text] [Related]

  • 8. Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy.
    Li M, Li Y, Huang X, Lu X.
    J Biomater Sci Polym Ed; 2015 Sep 23; 26(13):813-27. PubMed ID: 26166244
    [Abstract] [Full Text] [Related]

  • 9. Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
    Kong L, Wu Y, Alves CS, Shi X.
    Nanomedicine (Lond); 2016 Dec 23; 11(23):3103-3115. PubMed ID: 27809656
    [Abstract] [Full Text] [Related]

  • 10. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY, Park SJ, Park K, Kim KS, Lee H, Hahn SK.
    ACS Nano; 2011 Aug 23; 5(8):6138-47. PubMed ID: 21739990
    [Abstract] [Full Text] [Related]

  • 11. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW, Xiang B, Gao W, Yang ZZ, Li JQ, Qi XR.
    Biomaterials; 2013 Jul 23; 34(20):4849-59. PubMed ID: 23541420
    [Abstract] [Full Text] [Related]

  • 12. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R, Liu Y, Gao H, Kuang Q, Zhang Q, Tang J, Huang K, Chen X, Zhang Z, He Q.
    Int J Pharm; 2014 Dec 30; 477(1-2):590-600. PubMed ID: 25448564
    [Abstract] [Full Text] [Related]

  • 13. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
    Merkel OM, Beyerle A, Librizzi D, Pfestroff A, Behr TM, Sproat B, Barth PJ, Kissel T.
    Mol Pharm; 2009 Dec 30; 6(4):1246-60. PubMed ID: 19606864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS, Lee J, Kim HR, Chae SY, Kim M, Saravanakumar G, Yoon HY, You DG, Ko H, Kim K, Kwon IC, Park JC, Park JH.
    J Control Release; 2013 Jun 10; 168(2):105-14. PubMed ID: 23474029
    [Abstract] [Full Text] [Related]

  • 17. A Crosslinked Nucleic Acid Nanogel for Effective siRNA Delivery and Antitumor Therapy.
    Ding F, Mou Q, Ma Y, Pan G, Guo Y, Tong G, Choi CHJ, Zhu X, Zhang C.
    Angew Chem Int Ed Engl; 2018 Mar 12; 57(12):3064-3068. PubMed ID: 29364558
    [Abstract] [Full Text] [Related]

  • 18. Silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation using gold nanoparticles.
    Liu Z, Yan H, Li H.
    Environ Toxicol Pharmacol; 2017 Jul 12; 53():40-45. PubMed ID: 28501783
    [Abstract] [Full Text] [Related]

  • 19. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R, Liu Y, Gao H, Kuang Q, Zhang Q, Tang J, Fu H, Zhang Z, He Q.
    J Pharm Sci; 2015 Feb 12; 104(2):476-84. PubMed ID: 25256603
    [Abstract] [Full Text] [Related]

  • 20. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM, Jang M, Kim JH, Ahn HJ.
    Biomaterials; 2014 Aug 12; 35(25):7121-32. PubMed ID: 24854094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.